- Home
- BLNK vs PLRX Comparison
BLNK vs PLRX Comparison
Compare BLNK & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLNK | PLRX |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.6M | 79.9M |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BLNK | PLRX |
|---|---|---|
| Price | $0.67 | $1.28 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | $2.13 | ★ $3.75 |
| AVG Volume (30 Days) | ★ 1.8M | 763.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.94 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $126,197,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $17.87 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $1.09 |
| 52 Week High | $2.65 | $1.95 |
Technical Indicators
Market Signals| Indicator | BLNK | PLRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.59 | 54.70 |
| Support Level | $0.65 | $1.12 |
| Resistance Level | $0.74 | $1.36 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 34.42 | 76.09 |
Price Performance
Historical ComparisonAbout BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.